| 2022-05-12 | Immunic, Inc. IMUX | Executive Chairman | 10,000 0.0323% | $5.03 | $50,300 | -59.81% | ||
| 2021-08-10 | Immunic, Inc. IMUX | Executive Chairman | 1,000 0.004% | $9.80 | $9,800 | -5.42% | ||
| 2021-05-12 | Immunic, Inc. IMUX | Executive Chairman | 4,000 0.0186% | $12.75 | $51,000 | -21.89% | ||
| 2019-12-04 | Sale | Immunic, Inc. IMUX | director | 4,400 0.0423% | $6.96 | $30,624 | +75.82% | |
| 2018-02-15 | Sale | Akebia Therapeutics, Inc. AKBA | director | 2,000 0.0041% | $14.62 | $29,240 | -39.72% | |
| 2017-10-02 | Sale | Akebia Therapeutics, Inc. AKBA | director | 2,376 0.0049% | $19.64 | $46,665 | -45.25% | |
| 2017-07-03 | Sale | Akebia Therapeutics, Inc. AKBA | director | 1,980 0.0041% | $14.27 | $28,255 | -0.51% | |
| 2017-06-08 | Immunic, Inc. IMUX | President | 7,800 0.0186% | $3.12 | $24,364 | +74.6% | ||
| 2017-04-03 | Sale | Akebia Therapeutics, Inc. AKBA | director | 1,982 0.005% | $9.20 | $18,239 | +64.77% | |
| 2017-01-03 | Sale | Akebia Therapeutics, Inc. AKBA | director | 3,960 0.0102% | $10.46 | $41,422 | +33.48% | |
| 2016-10-03 | Sale | Akebia Therapeutics, Inc. AKBA | director | 3,962 0.0105% | $8.96 | $35,492 | +14.51% | |
| 2016-07-06 | Sale | Akebia Therapeutics, Inc. AKBA | director | 3,960 0.0098% | $7.48 | $29,637 | +14.7% | |
| 2015-10-02 | Sale | Akebia Therapeutics, Inc. AKBA | director | 1,992 0.0066% | $8.65 | $17,235 | -11.81% | |
| 2015-07-02 | Sale | Akebia Therapeutics, Inc. AKBA | director | 1,992 0.0067% | $9.53 | $18,980 | -8.32% | |
| 2015-04-02 | Sale | Akebia Therapeutics, Inc. AKBA | director | 1,992 0.0074% | $9.09 | $18,104 | -4.68% | |
| 2015-01-02 | Sale | Akebia Therapeutics, Inc. AKBA | director | 1,990 0.0099% | $11.46 | $22,807 | -16.09% | |
| 2015-01-01 | Sale | Akebia Therapeutics, Inc. AKBA | director | 995 0.0049% | $11.46 | $11,403 | ||
| 2014-12-26 | Sale | Akebia Therapeutics, Inc. AKBA | director | 15,507 0.0754% | $11.19 | $173,537 | -16.01% | |
| 2014-12-24 | Sale | Akebia Therapeutics, Inc. AKBA | director | 20,292 0.1016% | $11.26 | $228,567 | -14.07% | |
| 2014-10-08 | Immunic, Inc. IMUX | See Remarks | 200 0.0014% | $17.50 | $3,500 | +32.81% |